/PRNewswire/ JanOne (Nasdaq: JAN), the biopharmaceutical company focused on developing non-addicting painkillers and novel treatments for the causes of.
Abstract explained Jan101 s statistically significant reduction in pain and improvement in nerve conduction velocity in prior Phase II study.
LAS VEGAS, Aug. 25, 2023 /PRNewswire/ JanOne , the.
JanOne Technologies Announces Closing of Registered Direct Offering Priced At-The-Market under Nasdaq Rules streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
LAS VEGAS, Aug. 22, 2023 /PRNewswire/ JanOne , a biopharmaceutical company specializing in developing non-addicting pain killers and treatments for underlying causes of pain, today announced.